“Despite conflicting claims within the 'mood' pillar about the efficacy of AI in treating canine cancer, the overall assessment indicates a positive outlook based on the significant reduction in tumor size reported in the 'machine' pillar. The presence of stable claims in both the 'machine' and 'map' pillars reinforces the validity of utilizing AI tools for canine cancer treatment. Therefore, the risk is resolved by emphasizing the superior results documented in the 'machine' pillar, which suggests that while anecdotal claims vary, evidence-based results are compelling.”